Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial.
EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun.
EClinicalMedicine. 2023.
PMID: 37396807
Free PMC article.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.
Oliva S, Bruinink DHO, Rihova L, D'Agostino M, Pantani L, Capra A, van der Holt B, Troia R, Petrucci MT, Villanova T, Vsianska P, Jugooa R, Brandt-Hagens C, Gilestro M, Offidani M, Ribolla R, Galli M, Hajek R, Gay F, Cavo M, Omedé P, van der Velden VHJ, Boccadoro M, Sonneveld P.
Oliva S, et al. Among authors: villanova t.
Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.
Blood Cancer J. 2021.
PMID: 34083504
Free PMC article.
Clinical Trial.
Item in Clipboard
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase.
Gesmundo I, Di Blasio L, Banfi D, Villanova T, Fanciulli A, Favaro E, Gamba G, Musuraca C, Rapa I, Volante M, Munegato S, Papotti M, Gontero P, Primo L, Ghigo E, Granata R.
Gesmundo I, et al. Among authors: villanova t.
Cancer Lett. 2019 May 1;449:252-262. doi: 10.1016/j.canlet.2019.02.028. Epub 2019 Feb 18.
Cancer Lett. 2019.
PMID: 30790678
Item in Clipboard
The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors.
Gesmundo I, Villanova T, Gargantini E, Arvat E, Ghigo E, Granata R.
Gesmundo I, et al. Among authors: villanova t.
Front Endocrinol (Lausanne). 2016 Jun 16;7:66. doi: 10.3389/fendo.2016.00066. eCollection 2016.
Front Endocrinol (Lausanne). 2016.
PMID: 27379018
Free PMC article.
Item in Clipboard
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
Villanova T, Gesmundo I, Audrito V, Vitale N, Silvagno F, Musuraca C, Righi L, Libener R, Riganti C, Bironzo P, Deaglio S, Papotti M, Cai R, Sha W, Ghigo E, Schally AV, Granata R.
Villanova T, et al.
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 18.
Proc Natl Acad Sci U S A. 2019.
PMID: 30659154
Free PMC article.
Item in Clipboard
Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
Gesmundo I, Miragoli M, Carullo P, Trovato L, Larcher V, Di Pasquale E, Brancaccio M, Mazzola M, Villanova T, Sorge M, Taliano M, Gallo MP, Alloatti G, Penna C, Hare JM, Ghigo E, Schally AV, Condorelli G, Granata R.
Gesmundo I, et al. Among authors: villanova t.
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12033-12038. doi: 10.1073/pnas.1712612114. Epub 2017 Oct 25.
Proc Natl Acad Sci U S A. 2017.
PMID: 29078377
Free PMC article.
Item in Clipboard
Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function.
Gesmundo I, Villanova T, Banfi D, Gamba G, Granata R.
Gesmundo I, et al. Among authors: villanova t.
Front Endocrinol (Lausanne). 2017 Jul 3;8:143. doi: 10.3389/fendo.2017.00143. eCollection 2017.
Front Endocrinol (Lausanne). 2017.
PMID: 28729853
Free PMC article.
Review.
Item in Clipboard
Cite
Cite